SEC Form 4 · accession 0001493152-26-035122
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arnold M Baskies
Director
Period of report
Jul 27, 2026
Accepted (ET)
Jul 29, 2026 · 9:14 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2026 | M | 6,000 | $3.13 | A | 141,000 | D | |
| Common Stock | Jul 27, 2026 | F | 5,428 | $3.46 | D | 135,572 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $3.13 | Jul 27, 2026 | M | 6,000 | D | Aug 23, 2016 | Aug 23, 2026 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
- F2Right-To-Buy, pursuant to a stock option grant dated August 23, 2013.